Panagora Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.4M | Sell |
|
|||||
|
2025
Q2 | $30.2M | Sell |
|
|||||
|
2025
Q1 | $26.1M | Buy |
|
|||||
|
2024
Q4 | $13.1M | Sell |
|
|||||
|
2024
Q3 | $34.6M | Buy |
|
|||||
|
2024
Q2 | $4.81M | Buy |
|
|||||
|
2024
Q1 | $1.11M | Hold |
|
|||||
|
2023
Q4 | $1.43M | Hold |
|
|||||
|
2023
Q3 | $1.32M | Buy |
|
|||||
|
2023
Q2 | $973K | Hold |
|
|||||
|
2023
Q1 | $1.03M | Sell |
|
|||||
|
2022
Q4 | $1.25M | Sell |
|
|||||
|
2022
Q3 | $1.27M | Sell |
|
|||||
|
2022
Q2 | $958K | Hold |
|
|||||
|
2022
Q1 | $1.07M | Buy |
|
|||||
|
2021
Q4 | $567K | Sell |
|
|||||
|
2021
Q3 | $1.14M | Hold |
|
|||||
|
2021
Q2 | $1.02M | Sell |
|
|||||
|
2021
Q1 | $906K | Buy |
|
|||||
|
2020
Q4 | $646K | Buy |
|
|||||
|
2020
Q3 | $532K | Hold |
|
|||||
|
2020
Q2 | $541K | Buy |
|
|||||
|
2020
Q1 | $382K | Hold |
|
|||||
|
2019
Q4 | $404K | Buy |
|
|||||
|
2019
Q3 | $261K | Sell |
|
|||||
|
2019
Q2 | $287K | Hold |
|
|||||
|
2019
Q1 | $369K | Sell |
|
|||||
|
2018
Q4 | $341K | Buy |
|
|||||
|
2018
Q3 | $358K | Buy |
|
|||||
|
2018
Q2 | $307K | Buy |
|
|||||
|
2018
Q1 | $327K | Buy |
|
|||||
|
2017
Q4 | $346K | Hold |
|
|||||
|
2017
Q3 | $320K | Sell |
|
|||||
|
2017
Q2 | $346K | Buy |
|
|||||
|
2017
Q1 | $153K | Hold |
|
|||||
|
2016
Q4 | $112K | Hold |
|
|||||
|
2016
Q3 | $202K | Sell |
|
|||||
|
2016
Q2 | $218K | Sell |
|
|||||
|
2016
Q1 | $269K | Buy |
|
|||||
|
2015
Q4 | $311K | Sell |
|
|||||
|
2015
Q3 | $361K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $43K | Hold |
|
|||||
|
2014
Q1 | $45K | Sell |
|
|||||
|
2013
Q4 | $58K | Hold |
|
|||||
|
2013
Q3 | $58K | Buy |
|